Organic Process Research & Development · 2024 · 10 citations · 24 references
PharmacyMedicinal ChemistryOncologyCancer PharmacologyMolecular OncologySynthetic Medicinal ChemistryCatalytic MechanismsRetrosynthetic AnalysisAsymmetric Heterocycle SynthesisAsymmetric SynthesisEnantioselective SynthesisHer2-positive Breast Cancer TherapyHydrogenationHydrogenation Reactions
An asymmetric synthesis of cis-1,2-diaryltetralin ( 2 ), a key chiral intermediate in the synthesis of Vepdegestrant ( 1 ), an orally available PROTAC being evaluated for the treatment of ER+/HER2- breast cancer, is reported. Chirality is initially introduced via a catalytic enantioselective intramolecular Corey-Chaykovsky epoxidation utilizing isothiocineole, a chiral sulfide. Although several asymmetric intermolecular epoxidations using chiral sulfides have been reported, our approach represents a unique intramolecular variant. The subsequent introduction of the cis-1,2-diaryl motif is achieved via diastereoselective hydrogenation.
24
E. J. Corey, Michael Chaykovsky · Journal of the American Chemical Society · 1965 · 1.6K citations
Tehshik P. Yoon, Eric N. Jacobsen · Science · 2003 · 1.4K citations